Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection

OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a world-wide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, treatment of severe COVID-19 is far from clear. Therefore, it is urgent to develop an effective option for the treatment of patients with COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Bahari, Zahra, Jangravi, Zohreh, Ghoshooni, Hassan, Afarinesh, Mohammad Reza, Meftahi, Gholam Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894237/
https://www.ncbi.nlm.nih.gov/pubmed/33608746
http://dx.doi.org/10.1007/s00011-021-01445-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894237/
https://www.ncbi.nlm.nih.gov/pubmed/33608746
http://dx.doi.org/10.1007/s00011-021-01445-2

Ejemplares similares